Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_provenance.
- NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_provenance.
- NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_assertion evidence source_evidence_literature NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_provenance.
- NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_assertion SIO_000772 15709165 NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_provenance.
- NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_assertion wasDerivedFrom befree-20140225 NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_provenance.
- NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_assertion wasGeneratedBy ECO_0000203 NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP353500.RAdLIMj0fgobIj0lvzC8ufC841Y8TGlSaQx7PnP9pprOE130_provenance.